Chlamydia begins when the bacterium Chlamydia trachomatis passes from an infected person to someone else, overwhelmingly through sexual contact, and then hijacks cells lining the genitals, rectum, or throat. What makes this infection unusual is how the bacterium behaves once it arrives: it exists in two distinct forms, one built for traveling between people and another built for multiplying inside your cells, and it carries a molecular injection system that forces its way through cell membranes. That two-phase lifecycle, combined with a talent for dodging the immune system, is why chlamydia can establish itself so quietly that most people who have it never realize anything happened.
How It Spreads From Person to Person
The primary route is straightforward: unprotected sex. Vaginal, anal, and oral sex can all transmit C. trachomatis, though not equally. Condomless penile-anal sex is considered the major route of transmission, and penile-vaginal sex is similarly efficient.1PubMed Central. The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission Oral sex can transmit chlamydia to the throat, though pharyngeal infections tend to be less common and often clear on their own.
Transmission is messier than a single act might suggest. Mathematical modeling has shown that looking at oral and anal sex alone can explain infections at individual body sites, but it cannot account for people who are infected at multiple sites simultaneously. When researchers factored in what happens during a full sexual episode, like saliva on the penis from oral sex subsequently being introduced to the rectum during anal sex, the models finally matched real-world data on multisite infections.2PubMed Central. Chlamydia trachomatis transmission between the oropharynx, urethra and anorectum in men who have sex with men: a mathematical model In other words, the bacterium can hitch a ride between body sites during a single encounter, which partly explains why chlamydia shows up in places people do not expect.
A less common but medically important route is vertical transmission, meaning from a pregnant person to their baby during delivery. As the infant passes through an infected birth canal, it can pick up the bacterium, potentially leading to eye infections or pneumonia in the newborn. Registry data from Denmark estimated the risk of vertical transmission at roughly 1 to 2 percent among infected mothers, depending on how infection was measured.3PubMed. Probability of vertical transmission of Chlamydia trachomatis estimated from national registry data There is also evidence that the bacterium can reach the fetus before birth by infecting cells in the placenta or through contaminated amniotic fluid when membranes rupture prematurely.4PubMed Central. Identifying the Impact of Chlamydia trachomatis Screening and Treatment on Mother-to-Child Transmission, and Respiratory Neonatal Outcomes in Mexico
The Two Forms of the Bacterium
Understanding how chlamydia starts at a cellular level requires knowing that C. trachomatis is not one simple germ. It alternates between two fundamentally different forms during its lifecycle. The elementary body, or EB, is the tough, compact form designed for survival outside of cells and for infecting new ones. It does not replicate. The reticulate body, or RB, is the form that multiplies rapidly inside a host cell but cannot survive outside one and is not infectious on its own.5bioRxiv. Cell Type Development in Chlamydia trachomatis Follows a Program Intrinsic to the Reticulate Body Think of the EB as a seed built for dispersal and the RB as the plant that grows from it.
This two-form arrangement is central to how infection begins. The EB is what passes between people. Once it lands on a mucosal surface, it latches onto the cell and forces entry. Inside, it converts into RBs, which divide repeatedly within a membrane-enclosed compartment called an inclusion. After enough RBs have accumulated, they convert back into EBs, the host cell ruptures, and those new EBs spill out to infect neighboring cells or to be transmitted to a new person. The whole cycle takes roughly 48 to 72 hours.
Breaking Into a Cell
The moment of infection, the instant when chlamydia truly “starts,” is when an EB attaches to and penetrates an epithelial cell. The bacterium carries a molecular injection device called a type III secretion system, a needle-like structure that punctures the host cell membrane and pumps in preformed proteins. These proteins are effectors: they commandeer the cell’s internal machinery.
The process begins with the EB binding to sugar-coated proteins on the cell surface called heparan sulfate proteoglycans, using outer membrane proteins to anchor itself. That initial grip stabilizes the bacterium long enough for the type III secretion system to fire. The injected effectors then trigger the cell to reorganize its internal scaffolding, specifically its actin filaments, essentially convincing the cell to engulf the bacterium. Once inside, the EB sits within a membrane-bound compartment, the inclusion, which the bacterium actively remodels to prevent the cell from destroying it.6Nature / Communications Biology. Chlamydia trachomatis orchestrates multifaceted host cell manipulation for immune evasion The bacterium does not sneak in passively. It forces the door open and redecorates the room.
Why You Probably Would Not Notice
One of the most clinically important things about chlamydia is how often it produces no symptoms at all. Estimates vary, but a large majority of infections in women and a substantial proportion in men are asymptomatic. This is not an accident. C. trachomatis has evolved specific strategies to dampen or dodge the immune response.
The innate immune system, your body’s first line of defense, mounts an incomplete response to chlamydia. The bacterium interferes with the signaling pathways that would normally alert immune cells to an intruder, and the protective role of innate immunity turns out to be insufficient against it.7PubMed Central. Insights into innate immune cell evasion by Chlamydia trachomatis One concrete example: C. trachomatis produces a protein in high abundance called chlamydial protease activation factor. When the host cell eventually bursts and this protein spills out, it cleaves a receptor on neutrophils, the immune cells that should be killing the bacterium. This paralyzes the neutrophils’ ability to form extracellular traps and suppresses their oxidative burst, two of their main weapons.8The Journal of Infectious Diseases. Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways
The result is an infection that can simmer for weeks, months, or longer without the host ever mounting a strong enough response to clear it or to produce noticeable inflammation. This silent persistence is the reason routine screening matters so much: by the time symptoms appear, if they ever do, tissue damage may already be underway.
How Chlamydia Goes Dormant Under Stress
Even after infection is established, the bacterium has another trick. When conditions become hostile, whether from immune pressure, antibiotic exposure, nutrient starvation, or even co-infection with another pathogen, C. trachomatis can enter a persistence state. Instead of completing its normal cycle of replication, the RBs swell into enlarged, abnormal forms that stop dividing but remain alive.9PubMed Central. Persistence Alters the Interaction between Chlamydia trachomatis and Its Host Cell
This persistence state is reversible. Once the stress goes away, the aberrant RBs can resume normal development and produce new infectious EBs. In laboratory conditions, this dormancy has been triggered by exposure to penicillin, interferon-gamma from the immune system, iron depletion, and nutrient starvation, among other stressors.10The Journal of Infectious Diseases. Chlamydia trachomatis Persistence In Vitro: An Overview The ability to go dormant inside the cell, where the immune system cannot easily reach, and then reactivate later is one reason chlamydia can be so difficult to eliminate completely. It also raises questions about whether some apparent reinfections are actually reactivations of a persistent infection that was never fully cleared.
How Tissue Damage Happens Without Symptoms
If chlamydia is often silent, how does it cause serious complications like pelvic inflammatory disease, fallopian tube scarring, and infertility? The damage comes not from the bacterium itself but from the immune response it provokes. C. trachomatis manipulates host cell processes in ways that activate inflammatory signaling pathways, pulling in waves of innate immune cells and triggering the release of tissue-damaging proteins and pro-inflammatory molecules.11PubMed Central. Chlamydia trachomatis Genital Infections
Research using mouse models has pinpointed one particular molecule, interleukin-1 alpha (IL-1α), as a key driver. This molecule is released when infected cells die during the inflammatory process. It recruits neutrophils to the reproductive tract, and those neutrophils cause collateral damage to surrounding tissue. In experiments where IL-1α was blocked with antibodies, infection-induced damage to the oviducts was prevented.8The Journal of Infectious Diseases. Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways The cruel irony is that the bacterium’s ability to partially suppress immunity means the immune response keeps grinding away at the tissue without ever finishing the job. Repeated or prolonged infections compound this scarring.
Reinfection and the Immunity Problem
A natural question after learning how chlamydia establishes itself: does your body learn to fight it off? The short answer is that natural immunity to chlamydia is weak and unreliable. In one study following women who were found to be infected, about 22 percent spontaneously cleared the infection on their own within one to seven weeks before treatment. However, reinfection was common, with roughly 17 percent testing positive again about six months after antibiotic treatment.12The Journal of Infectious Diseases. Immunity to Chlamydia trachomatis
There was an interesting wrinkle: women who had spontaneously cleared the infection before treatment were significantly less likely to be reinfected afterward compared to those who were still positive when they received antibiotics. Only about 5 percent of the spontaneous clearers were reinfected, versus 20 percent of those who were persistently positive.12The Journal of Infectious Diseases. Immunity to Chlamydia trachomatis This suggests that mounting a successful immune response on your own confers some protection, while being treated with antibiotics before your immune system finishes the job does not teach the body much. It is one reason a chlamydia vaccine remains an active area of research: natural exposure does not reliably do what vaccines ideally would.
The Vaginal Microbiome as a Gatekeeper
Whether chlamydia gains a foothold depends partly on who is already living in the neighborhood. The vaginal microbiome, the community of bacteria normally present in the reproductive tract, plays a documented role in susceptibility to C. trachomatis.
A systematic review and meta-analysis found that women with a vaginal microbiome dominated by hydrogen peroxide-producing Lactobacillus species were less likely to be infected with chlamydia.13PubMed Central. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis More specifically, Lactobacillus species that produce a particular form of lactic acid, d-lactic acid, were associated with long-term protection against chlamydia. This is consistent with the observation that Lactobacillus iners, a species that does not produce this form, offered less protection.14PubMed Central. The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection The mechanism is not fully worked out, but the acidic environment and specific metabolic products of a healthy Lactobacillus-dominated microbiome appear to make it harder for the bacterium to establish an infection. This is one reason disruptions to vaginal flora, whether from douching, antibiotics for unrelated conditions, or other factors, can increase vulnerability to sexually transmitted infections.
Different Strains, Different Diseases
Not all chlamydia is created equal. C. trachomatis comes in multiple serovars, essentially different genetic varieties, and which one infects you determines a lot about what happens next. Serovars A through C cause trachoma, a blinding eye disease spread primarily in childhood in developing countries. Serovars D through K are the ones responsible for the common genital and rectal infections most people think of when they hear “chlamydia.” These serovars stick to the surface of mucosal tissue and produce superficial infections.
Then there are serovars L1, L2, and L3, which cause lymphogranuloma venereum (LGV). Unlike standard genital chlamydia, LGV serovars can invade past the mucosal surface and into regional lymph nodes. The disease progresses through three stages: a painless sore at the site of infection, swelling and inflammation in nearby lymph nodes, and eventually irreversible destruction of lymph tissue if untreated.15PubMed Central. Approach to lymphogranuloma venereum The fact that one species of bacterium can cause a mild, often-unnoticed genital infection, a devastating eye disease in children, and an aggressive lymph node infection depending on which serovar is involved speaks to the evolutionary pressures that have shaped C. trachomatis over a very long time.
Genomic analysis of 60 Chlamydia strains has identified positively selected genes that appear to be involved in the infection of different human cell types, including the columnar epithelial cells of the eye and genitals and the immune cells called mononuclear phagocytes that LGV serovars target.16PubMed Central. Directional evolution of Chlamydia trachomatis towards niche-specific adaptation The different serovars are essentially the same species that has evolved specialized toolkits for different tissues.
Trachoma and Non-Sexual Transmission
The trachoma serovars introduce a completely different transmission story. In many parts of sub-Saharan Africa and South Asia, chlamydia spreads between children’s eyes without any sexual contact, often facilitated by flies. The species Musca sorbens, a type of fly attracted to eyes, is considered the principal insect vector. In one study in The Gambia, M. sorbens made up less than 10 percent of total flies caught in traps but was responsible for over 90 percent of fly-eye contacts with children.17PubMed. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma
More recent field work has confirmed the link more directly. In households where children had active ocular chlamydia, about 22 percent of caught flies tested positive for the bacterium’s DNA, compared to only 1.5 percent of flies in households without ocular infection. Fly positivity dropped off sharply beyond 200 meters from an infected household, and electron microscopy showed chlamydial elementary bodies physically adhering to the hairs and bristles on the flies’ bodies.18PLOS Neglected Tropical Diseases. Field- and laboratory-based studies on correlates of Chlamydia trachomatis transmission by Musca sorbens The flies act as short-range shuttles, picking up EBs from an infected child’s eye discharge and depositing them on another child’s face.
Contaminated surfaces can also play a role, though a limited one. Laboratory studies have shown that C. trachomatis can remain viable on plastic, skin, and cotton cloth for up to 24 hours depending on the amount of bacteria present.19PLoS Neglected Tropical Diseases. Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma Under typical indoor humidity, though, survival on a nonporous plastic surface dropped to 50 percent within about five minutes, and complete desiccation killed the organisms within 45 minutes. Humid conditions extended viability considerably, with positive samples still recoverable after three hours.20PubMed. Chlamydia trachomatis can be transmitted by a nonporous plastic surface in vitro For genital chlamydia, fomite transmission is considered negligible. For trachoma in crowded, humid environments where face-washing opportunities are scarce, shared towels and bedding are plausible contributors.
What Happens When Gonorrhea Is Already There
Chlamydia and gonorrhea are frequently detected together, and their co-infection is not just a coincidence of shared risk factors. Laboratory co-infection experiments have revealed that when Neisseria gonorrhoeae (the bacterium causing gonorrhea) is present in the same cells as C. trachomatis, the chlamydial developmental cycle is impaired. After 12 hours of co-infection, researchers observed fewer infectious EBs compared to chlamydia growing alone, even though the total amount of chlamydial DNA remained the same. The chlamydia was still alive but not completing its cycle, a hallmark of the persistence state described earlier.21PubMed Central. Neisseria gonorrhoeae drives Chlamydia trachomatis into a persistence-like state during in vitro co-infection
This matters for diagnosis and treatment. If gonorrhea pushes chlamydia into dormancy, standard tests that look for actively replicating bacteria might miss the chlamydial infection. And if the gonorrhea is treated but the dormant chlamydia is not, the chlamydia can resume its normal lifecycle once the competing pathogen is gone. It is one practical reason that clinicians often treat for both infections simultaneously when either one is detected.
An Ancient Parasite With a Long History
Chlamydia did not evolve to infect humans specifically. Genomic analysis suggests that the last common ancestor of modern pathogenic and symbiotic chlamydiae was already adapted to intracellular survival in early single-celled organisms roughly 700 million years ago, well before animals existed. That ancestor already possessed a type III secretion system and many of the virulence factors found in today’s disease-causing species.22PubMed. Illuminating the evolutionary history of chlamydiae Chlamydiae appear to be among the original pioneers of intracellular parasitism in eukaryotic life.
The broader Chlamydia family infects an enormous range of hosts. Chlamydia psittaci, for instance, causes psittacosis, a respiratory illness transmissible from birds to humans. A systematic review identified genotypic matches between human and bird cases involving chickens, turkeys, pigeons, ducks, geese, songbirds, parrots, and owls, among others.23PubMed Central. Animal sources for zoonotic transmission of psittacosis: a systematic review Other chlamydial species infect koalas, cattle, cats, and reptiles. C. trachomatis is the one that has specialized in humans, but it sits within a family of bacteria that has been exploiting the insides of cells for hundreds of millions of years. The toolkit it uses to invade your cells, hide from your immune system, and go dormant under stress is not a recent invention. It is the product of an extraordinarily long evolutionary arms race between intracellular parasites and the hosts they depend on.